
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $51M | $988M | $975M | $981M | $1B | |
Revenue Growth (YoY) | 240% | 1837.26% | -1.32% | 0.62% | 3.57% | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $76M | $442M | $432M | $433M | $460M | |
Other Inc / (Exp) | $449M | $1.1B | $1.6B | $1B | $1.2B | |
Operating Expenses | $111M | $991M | $947M | $908M | $924M | |
Operating Income | -$60M | -$3M | $28M | $73M | $92M | |
Net Interest Expenses | $28M | $117M | $133M | $206M | $194M | |
EBT. Incl. Unusual Items | $361M | $950M | $1.5B | $888M | $1.1B | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$37M | $218M | $277M | $200M | $213M | |
Net Income to Company | $398M | $732M | $1.3B | $688M | $869M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $398M | $732M | $1.3B | $688M | $869M | |
Basic EPS (Cont. Ops) | $2.18 | $3.97 | $8.01 | $4.71 | $6.08 | |
Diluted EPS (Cont. Ops) | $2.17 | $3.93 | $7.96 | $4.71 | $6.08 | |
Weighted Average Basic Share | $182M | $185M | $157M | $146M | $143M | |
Weighted Average Diluted Share | $183.2M | $186M | $158M | $147M | $143M | |
EBITDA | $404M | $1.3B | $1.9B | $1.3B | $1.5B | |
EBIT | $389M | $1.1B | $1.7B | $1.1B | $1.3B | |
Revenue (Reported) | $51M | $988M | $975M | $981M | $1B | |
Operating Income (Reported) | -$60M | -$3M | $28M | $73M | $92M | |
Operating Income (Adjusted) | $389M | $1.1B | $1.7B | $1.1B | $1.3B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $247M | $238M | $246M | $245M | $266M | |
Revenue Growth (YoY) | 5918.52% | -3.64% | 3.36% | -0.41% | 8.57% | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $105M | $101M | $110M | $105M | $112M | |
Other Inc / (Exp) | $88M | $363M | $121M | $332M | $261M | |
Operating Expenses | $238M | $231M | $230M | $217M | $223M | |
Operating Income | $9M | $7M | $16M | $28M | $43M | |
Net Interest Expenses | $33M | $26M | $45M | $51M | $40M | |
EBT. Incl. Unusual Items | $64M | $344M | $92M | $309M | $264M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $12M | $45M | $23M | $68M | -$4M | |
Net Income to Company | $52M | $299M | $69M | $241M | $268M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $52M | $299M | $69M | $241M | $268M | |
Basic EPS (Cont. Ops) | $0.27 | $1.79 | $0.47 | $1.69 | $1.87 | |
Diluted EPS (Cont. Ops) | $0.27 | $1.77 | $0.47 | $1.69 | $1.87 | |
Weighted Average Basic Share | $194M | $167M | $146M | $143M | $143M | |
Weighted Average Diluted Share | $196M | $169M | $147M | $143M | $143M | |
EBITDA | $161M | $434M | $195M | $410M | $357M | |
EBIT | $97M | $370M | $137M | $360M | $304M | |
Revenue (Reported) | $247M | $238M | $246M | $245M | $266M | |
Operating Income (Reported) | $9M | $7M | $16M | $28M | $43M | |
Operating Income (Adjusted) | $97M | $370M | $137M | $360M | $304M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $293.9M | $979M | $983M | $980M | $1B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $172.6M | $438M | $441M | $428M | $467M | |
Other Inc / (Exp) | $534.5M | $1.3B | $1.4B | $1.2B | $1.1B | |
Operating Expenses | $337.6M | $984M | $946M | $895M | $930M | |
Operating Income | -$43.7M | -$5M | $37M | $85M | $107M | |
Net Interest Expenses | $55.1M | $110M | $152M | $212M | $183M | |
EBT. Incl. Unusual Items | $435.6M | $1.2B | $1.3B | $1.1B | $1B | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$22.2M | $251M | $255M | $245M | $141M | |
Net Income to Company | $457.8M | $979M | $1B | $860M | $896M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $457.8M | $979M | $1B | $860M | $896M | |
Basic EPS (Cont. Ops) | $2.50 | $5.53 | $6.70 | $5.93 | $6.26 | |
Diluted EPS (Cont. Ops) | $2.48 | $5.47 | $6.65 | $5.90 | $6.26 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $569.3M | $1.6B | $1.7B | $1.5B | $1.4B | |
EBIT | $490.8M | $1.3B | $1.4B | $1.3B | $1.2B | |
Revenue (Reported) | $293.9M | $979M | $983M | $980M | $1B | |
Operating Income (Reported) | -$43.7M | -$5M | $37M | $85M | $107M | |
Operating Income (Adjusted) | $490.8M | $1.3B | $1.4B | $1.3B | $1.2B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $247M | $238M | $246M | $245M | $266M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $105M | $101M | $110M | $105M | $112M | |
Other Inc / (Exp) | $88M | $363M | $121M | $332M | $261M | |
Operating Expenses | $238M | $231M | $230M | $217M | $223M | |
Operating Income | $9M | $7M | $16M | $28M | $43M | |
Net Interest Expenses | $33M | $26M | $45M | $51M | $40M | |
EBT. Incl. Unusual Items | $64M | $344M | $92M | $309M | $264M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $12M | $45M | $23M | $68M | -$4M | |
Net Income to Company | $52M | $299M | $69M | $241M | $268M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $52M | $299M | $69M | $241M | $268M | |
Basic EPS (Cont. Ops) | $0.27 | $1.79 | $0.47 | $1.69 | $1.87 | |
Diluted EPS (Cont. Ops) | $0.27 | $1.77 | $0.47 | $1.69 | $1.87 | |
Weighted Average Basic Share | $194M | $167M | $146M | $143M | $143M | |
Weighted Average Diluted Share | $196M | $169M | $147M | $143M | $143M | |
EBITDA | $161M | $434M | $195M | $410M | $357M | |
EBIT | $97M | $370M | $137M | $360M | $304M | |
Revenue (Reported) | $247M | $238M | $246M | $245M | $266M | |
Operating Income (Reported) | $9M | $7M | $16M | $28M | $43M | |
Operating Income (Adjusted) | $97M | $370M | $137M | $360M | $304M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $1.4B | $191M | $375M | $158M | $163M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $349M | $206M | $201M | $178M | $195M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $79M | $62M | $84M | $94M | $65M | |
Total Current Assets | $1.8B | $459M | $660M | $430M | $423M | |
Property Plant And Equipment | $1.1B | $1B | $1B | $1.1B | $1.2B | |
Long-Term Investments | $16.2B | $13.3B | $11.4B | $12.1B | $13.1B | |
Goodwill | $746M | $762M | $755M | $755M | $755M | |
Other Intangibles | $1.3B | $1.2B | $1.1B | $1.1B | $1B | |
Other Long-Term Assets | $151M | $296M | $180M | $236M | $300M | |
Total Assets | $21.4B | $17B | $15.1B | $15.6B | $16.7B | |
Accounts Payable | -- | -- | -- | -- | -- | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | $113M | $106M | $137M | $59M | $64M | |
Total Current Liabilities | $612M | $582M | $1.7B | $178M | $200M | |
Long-Term Debt | $4.8B | $3.7B | $2.4B | $3.7B | $3.8B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $7.9B | $6.8B | $6.6B | $6.6B | $6.9B | |
Common Stock | $2M | $1M | $1M | $1M | $1M | |
Other Common Equity Adj | $15M | $14M | $9M | $52M | $73M | |
Common Equity | $13.5B | $10.1B | $8.5B | $9B | $9.8B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $12M | $12M | $18M | $20M | $15M | |
Total Equity | $13.5B | $10.1B | $8.5B | $9B | $9.8B | |
Total Liabilities and Equity | $21.4B | $17B | $15.1B | $15.6B | $16.7B | |
Cash and Short Terms | $1.4B | $191M | $375M | $158M | $163M | |
Total Debt | $4.8B | $3.8B | $3.8B | $3.7B | $3.8B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $1.2B | $300M | $169M | $108M | $226M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $201.2M | $169M | $194M | $186M | $174M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $83M | $77M | $91M | $56M | $397M | |
Total Current Assets | $1.5B | $546M | $454M | $350M | $797M | |
Property Plant And Equipment | $1.1B | $1B | $1B | $1.1B | $1.2B | |
Long-Term Investments | $15.7B | $12.9B | $11.6B | $12.3B | $13.1B | |
Goodwill | $764.7M | $762M | $755M | $755M | $755M | |
Other Intangibles | $1.2B | $1.1B | $1.1B | $1B | $992M | |
Other Long-Term Assets | $160.5M | $201M | $206M | $237M | $227M | |
Total Assets | $20.5B | $16.6B | $15.1B | $15.7B | $17B | |
Accounts Payable | -- | -- | -- | -- | -- | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | $133.5M | $154M | $152M | $67M | $77M | |
Total Current Liabilities | $676.1M | $537M | $293M | $193M | $573M | |
Long-Term Debt | $4.6B | $4B | $3.7B | $3.6B | $3.4B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $7.7B | $7B | $6.5B | $6.6B | $6.9B | |
Common Stock | $1.9M | $1M | $1M | $1M | $1M | |
Other Common Equity Adj | $15.6M | $10M | $59M | $35M | $60M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $11.7M | $16M | $18M | $20M | $15M | |
Total Equity | $12.8B | $9.6B | $8.6B | $9.2B | $10.1B | |
Total Liabilities and Equity | $20.5B | $16.6B | $15.1B | $15.7B | $17B | |
Cash and Short Terms | $1.2B | $300M | $169M | $108M | $226M | |
Total Debt | $4.6B | $4B | $3.7B | $3.6B | $3.8B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $398M | $732M | $1.3B | $688M | $869M | |
Depreciation & Amoritzation | $15M | $267M | $262M | $230M | $207M | |
Stock-Based Compensation | $9M | $41M | $37M | $34M | $28M | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$96M | $3M | -$56M | $16M | $104M | |
Capital Expenditures | $2M | $134M | $181M | $222M | $247M | |
Cash Acquisitions | $577M | $4.2B | $3.2B | $394M | $335M | |
Cash From Investing | $575M | $4.1B | $3B | $150M | $130M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $2.8B | $1.5B | $325M | $1.5B | $1.1B | |
Long-Term Debt Repaid | -$1.3B | -$2.5B | -$231M | -$1.6B | -$1.2B | |
Repurchase of Common Stock | -$597M | -$4.3B | -$2.9B | -$227M | -$89M | |
Other Financing Activities | -$23M | -$11M | -$9M | -$48M | -$30M | |
Cash From Financing | $904M | -$5.3B | -$2.8B | -$390M | -$181M | |
Beginning Cash (CF) | $50M | $1.4B | $206M | $400M | $176M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $1.4B | -$1.2B | $194M | -$224M | $53M | |
Ending Cash (CF) | $1.4B | $206M | $400M | $176M | $229M | |
Levered Free Cash Flow | -$98M | -$131M | -$237M | -$206M | -$143M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $52M | $299M | $69M | $241M | $268M | |
Depreciation & Amoritzation | $64M | $64M | $58M | $50M | $53M | |
Stock-Based Compensation | $10M | $9M | $8M | $7M | $3M | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $193M | $90M | $41M | $52M | $78M | |
Capital Expenditures | $28M | $32M | $54M | $61M | $65M | |
Cash Acquisitions | $518M | $602M | $42M | $81M | $300M | |
Cash From Investing | $490M | $574M | -$12M | $18M | $257M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | $300M | $1.2B | $20M | $451M | |
Long-Term Debt Repaid | -$183M | -$2M | -$1.4B | -$62M | -$449M | |
Repurchase of Common Stock | -$738M | -$843M | -$40M | -$89M | -- | |
Other Financing Activities | -$2M | -$3M | -$27M | -$1M | -$1M | |
Cash From Financing | -$923M | -$548M | -$235M | -$132M | $1M | |
Beginning Cash (CF) | $1.4B | $206M | $400M | $176M | $229M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$240M | $116M | -$206M | -$62M | $336M | |
Ending Cash (CF) | $1.2B | $322M | $194M | $114M | $565M | |
Levered Free Cash Flow | $165M | $58M | -$13M | -$9M | $13M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $457.8M | $979M | $1B | $860M | $896M | |
Depreciation & Amoritzation | $78.5M | $267M | $256M | $222M | $210M | |
Stock-Based Compensation | $17.2M | $40M | $36M | $33M | $24M | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $111.5M | -$100M | -$105M | $27M | $130M | |
Capital Expenditures | $30M | $138M | $203M | $229M | $251M | |
Cash Acquisitions | $1.1B | $4.3B | $2.6B | $433M | $554M | |
Cash From Investing | $1.1B | $4.1B | $2.5B | $180M | $369M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $2.8B | $1.8B | $1.3B | $273M | $1.6B | |
Long-Term Debt Repaid | -$1.5B | -$2.3B | -$1.6B | -$262M | -$1.6B | |
Repurchase of Common Stock | -$1.3B | -$4.4B | -$2.1B | -$276M | -- | |
Other Financing Activities | -$23.1M | -$12M | -$33M | -$22M | -$30M | |
Cash From Financing | -$17.1M | -$4.9B | -$2.5B | -$287M | -$48M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $1.2B | -$871M | -$128M | -$80M | $451M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $81.5M | -$238M | -$308M | -$202M | -$121M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $52M | $299M | $69M | $241M | $268M | |
Depreciation & Amoritzation | $64M | $64M | $58M | $50M | $53M | |
Stock-Based Compensation | $10M | $9M | $8M | $7M | $3M | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $193M | $90M | $41M | $52M | $78M | |
Capital Expenditures | $28M | $32M | $54M | $61M | $65M | |
Cash Acquisitions | $518M | $602M | $42M | $81M | $300M | |
Cash From Investing | $490M | $574M | -$12M | $18M | $257M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | $300M | $1.2B | $20M | $451M | |
Long-Term Debt Repaid | -$183M | -$2M | -$1.4B | -$62M | -$449M | |
Repurchase of Common Stock | -$738M | -$843M | -$40M | -$89M | -- | |
Other Financing Activities | -$2M | -$3M | -$27M | -$1M | -$1M | |
Cash From Financing | -$923M | -$548M | -$235M | -$132M | $1M | |
Beginning Cash (CF) | $1.4B | $206M | $400M | $176M | $229M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$240M | $116M | -$206M | -$62M | $336M | |
Ending Cash (CF) | $1.2B | $322M | $194M | $114M | $565M | |
Levered Free Cash Flow | $165M | $58M | -$13M | -$9M | $13M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.